台耀 (4746.TW)

94.00 -0.70 (-0.74%) 收市：01:30PM CST

台耀

No. 36, Hoping Street
Louchu
Taoyuan 33842
Taiwan
886 3 324 0895
https://www.formosalab.com

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Chen-Yu Cheng Ph.D.	President & Chairman of the Board	7.94M	無	無
Ms. S. J. Liou B.S.	Senior Vice President of Business	無	無	無
Ms. Michelle Lo	Senior Vice President of Corporate Support Division	無	無	無
Mr. Hengui Huang	Senior Vice President of Quality & Regulatory Compliance Division	無	無	無
Mr. Hank Chen	Senior Vice President of Production	無	無	無
Xian-Gui Huang	Vice President	無	無	無
Ling-Fang Yang	Vice President	無	無	無
Chien-Fei Lin	Chief Information Security Officer	無	無	無

截止 2022年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 TWD。

描述

Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers worldwide. It offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, antibiotics, potassium binders, and other areas. The company also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. In addition, it is involved in chemical trading; investment; and wholesale of chemical raw materials and products, as well as commission agency activities. Formosa Laboratories, Inc. was incorporated in 1985 and is headquartered in Taoyuan, Taiwan.

公司管治

截至 無 止，台耀 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。